Macrophage scavenger receptor class A - A multifunctional receptor in atherosclerosis

被引:205
作者
de Winther, MPJ
van Dijk, KW
Havekes, LM
Hofker, MH
机构
[1] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RA Leiden, Netherlands
[2] TNO, PG, Gaubius Lab, NL-2300 AK Leiden, Netherlands
关键词
inflammation; cardiovascular disease; modified lipoprotein; transgenic mouse;
D O I
10.1161/01.ATV.20.2.290
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In atherogenesis, elevated plasma levels of low density lipoprotein (LDL) lead to the chronic presence of LDL in the arterial wall. There, LDL is modified (eg, oxidized), and these modified lipoproteins activate endothelial cells, which attract circulating monocytes. These monocytes enter the vessel wall, differentiate into macrophages, and subject the modified lipoproteins to endocytosis through scavenger receptor pathways. This unrestricted uptake, which is not limited by intracellular cholesterol levels, eventually leads to the formation of lipid-filled foam cells, the initial step in atherosclerosis. Macrophage scavenger receptor class A (SRA) is thought to be one of the main receptors involved in foam cell formation, mediating the influx of lipids into the macrophages. In addition to this role in modified lipoprotein uptake by macrophages. the SRA has been shown to be important in the inflammatory response in host defense, cellular activation, adhesion, and cell-cell interaction. Given the importance of these processes in atherogenesis, these latter functions may prove to make the SRA a multifunctional player in the atherosclerotic process.
引用
收藏
页码:290 / 297
页数:8
相关论文
共 92 条
[81]   Uptake and catabolism of modified LDL in scavenger-receptor class A type I/II knock-out mice [J].
Van Berkel, TJC ;
Van Velzen, A ;
Kruijt, JK ;
Suzuki, H ;
Kodama, T .
BIOCHEMICAL JOURNAL, 1998, 331 :29-35
[82]  
VANDENMAAGDENBERG AMJM, 1993, J BIOL CHEM, V268, P10540
[83]   Decrease in scavenger receptor expression in human monocyte-derived macrophages treated with granulocyte macrophage colony-stimulating factor [J].
vanderKooij, MA ;
Morand, OH ;
Kempen, HJ ;
vanBerkel, TJC .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (01) :106-114
[84]   DIET-INDUCED HYPERLIPOPROTEINEMIA AND ATHEROSCLEROSIS IN APOLIPOPROTEIN E3 LEIDEN TRANSGENIC MICE [J].
VANVLIJMEN, BJM ;
VANDENMAAGDENBERG, AMJM ;
GIJBELS, MJJ ;
VANDERBOOM, H ;
HOGENESCH, H ;
FRANTS, RR ;
HOFKER, MH ;
HAVEKES, LM .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (04) :1403-1410
[85]   HEPATIC OVEREXPRESSION OF BOVINE SCAVENGER RECEPTOR-TYPE-I IN TRANSGENIC MICE PREVENTS DIET-INDUCED HYPERBETALIPOPROTEINEMIA [J].
WOLLE, S ;
VIA, DP ;
CHAN, L ;
CORNICELLI, JA ;
BISGAIER, CL .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :260-272
[86]   COMBINATORIAL INTERACTIONS BETWEEN AP-1 AND ETS DOMAIN PROTEINS CONTRIBUTE TO THE DEVELOPMENTAL REGULATION OF THE MACROPHAGE SCAVENGER RECEPTOR GENE [J].
WU, H ;
MOULTON, K ;
HORVAI, A ;
PARIK, S ;
GLASS, CK .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (03) :2129-2139
[87]   Oxidized low density lipoproteins alter macrophage lipid uptake apoptosis, viability and nitric oxide synthesis [J].
Yang, XC ;
Galeano, NF ;
Szabolcs, M ;
Sciacca, RR ;
Cannon, PJ .
JOURNAL OF NUTRITION, 1996, 126 (04) :S1072-S1075
[88]   GENE-EXPRESSION IN MACROPHAGE-RICH HUMAN ATHEROSCLEROTIC LESIONS - 15-LIPOXYGENASE AND ACETYL LOW-DENSITY-LIPOPROTEIN RECEPTOR MESSENGER-RNA COLOCALIZE WITH OXIDATION SPECIFIC LIPID-PROTEIN ADDUCTS [J].
YLAHERTTUALA, S ;
ROSENFELD, ME ;
PARTHASARATHY, S ;
SIGAL, E ;
SARKIOJA, T ;
WITZTUM, JL ;
STEINBERG, D .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (04) :1146-1152
[89]   COLOCALIZATION OF 15-LIPOXYGENASE MESSENGER-RNA AND PROTEIN WITH EPITOPES OF OXIDIZED LOW-DENSITY-LIPOPROTEIN IN MACROPHAGE-RICH AREAS OF ATHEROSCLEROTIC LESIONS [J].
YLAHERTTUALA, S ;
ROSENFELD, ME ;
PARTHASARATHY, S ;
GLASS, CK ;
SIGAL, E ;
WITZTUM, JL ;
STEINBERG, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) :6959-6963
[90]   EVIDENCE FOR THE PRESENCE OF OXIDATIVELY MODIFIED LOW-DENSITY LIPOPROTEIN IN ATHEROSCLEROTIC LESIONS OF RABBIT AND MAN [J].
YLAHERTTUALA, S ;
PALINSKI, W ;
ROSENFELD, ME ;
PARTHASARATHY, S ;
CAREW, TE ;
BUTLER, S ;
WITZTUM, JL ;
STEINBERG, D .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) :1086-1095